GlassScriptPhysician profile
Nisha D Gosai
NPI 1235620634
$2,418.41
in general payments reported to CMS, 2019-2025
15 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2021: $201 · 2022: $206 · 2023: $345 · 2024: $1,079 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,113.21 | 2021-2025 | Clareon, Centurion, Clareon Panoptix Pro |
| Dompe US, INC. | $272.22 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $243.58 | 2024-2025 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Glaukos Corporation | $203.62 | 2021-2024 | Istent Inject Trabecular Micro-Bypass System |
| Johnson & Johnson Surgical Vision, INC. | $138.22 | 2022-2024 | Tecnis Iol |
| Allergan, INC. | $99.99 | 2019 | |
| Alimera Sciences, INC. | $90.23 | 2022 | |
| Biotissue Holdings INC. | $87.26 | 2024 | |
| Thea Pharma INC. | $56.41 | 2024-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $24.83 | 2024 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $24.58 | 2019 | |
| New World Medical,INC. | $18.73 | 2023 | |
| Oyster Point Pharma, INC. | $15.91 | 2022 | |
| Eyepoint US, INC. | $15.46 | 2019 | |
| Sight Sciences, INC. | $14.16 | 2025 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Gosai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.